SE7514177L - Nya 4-arylpiperidinderivat och forfaranden for deras framstellning - Google Patents

Nya 4-arylpiperidinderivat och forfaranden for deras framstellning

Info

Publication number
SE7514177L
SE7514177L SE7514177A SE7514177A SE7514177L SE 7514177 L SE7514177 L SE 7514177L SE 7514177 A SE7514177 A SE 7514177A SE 7514177 A SE7514177 A SE 7514177A SE 7514177 L SE7514177 L SE 7514177L
Authority
SE
Sweden
Prior art keywords
arylpiperide
individuals
procedures
preparation
new
Prior art date
Application number
SE7514177A
Other languages
English (en)
Swedish (sv)
Inventor
R Kubela
Nascimento J M Do
Original Assignee
Delmar Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delmar Chem filed Critical Delmar Chem
Publication of SE7514177L publication Critical patent/SE7514177L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7514177A 1974-12-17 1975-12-16 Nya 4-arylpiperidinderivat och forfaranden for deras framstellning SE7514177L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/533,642 US4048314A (en) 1974-12-17 1974-12-17 Morpholino containing 4-arylpiperidine derivatives
BE163778A BE837878A (fr) 1974-12-17 1976-01-23 4-arylpiperidines et procedes pour les preparer

Publications (1)

Publication Number Publication Date
SE7514177L true SE7514177L (sv) 1976-06-18

Family

ID=25649081

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514177A SE7514177L (sv) 1974-12-17 1975-12-16 Nya 4-arylpiperidinderivat och forfaranden for deras framstellning

Country Status (6)

Country Link
US (2) US4048314A (fr)
AU (1) AU1038176A (fr)
BE (1) BE837878A (fr)
CA (1) CA1053230A (fr)
FI (1) FI753525A (fr)
SE (1) SE7514177L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286095A (en) * 1976-08-05 1981-08-25 Canada Packers Inc. 4-Arylpiperidine derivatives
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
SE0401465D0 (sv) * 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
HUE029790T2 (hu) * 2004-10-13 2017-04-28 Teva Pharmaceuticals Int Gmbh Eljárás 4-(3-metánszulfonil-fenil)-l-N-propil-piperidin elõállítására
CN101068782A (zh) * 2004-10-13 2007-11-07 神经研究瑞典公司 合成4-(3-磺酰基苯基)-哌啶类的方法
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump
CN102766079B (zh) * 2011-05-06 2015-04-08 上海医药工业研究院 一类吡咯烷衍生物、其制备方法及应用
UY34503A (es) 2011-12-08 2013-07-31 Ivax Int Gmbh ?sal de bromhidrato de pridopidina?
AU2013243461A1 (en) 2012-04-04 2014-11-06 Teva Pharmaceuticals International Gmbh Pharmaceutical compositions for combination therapy
WO2018094275A1 (fr) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Promédicaments de l'alvocidib et leur utilisation en tant qu'inhibiteurs de protéines kinases
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
US11325768B2 (en) 2018-07-20 2022-05-10 The Procter & Gamble Company Flexible package and method of manufacture
US11034710B2 (en) 2018-12-04 2021-06-15 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125574A (en) * 1964-03-17 I-aroylpropylx-acyl-x-amino-
US2167351A (en) * 1937-08-07 1939-07-25 Winthrop Chem Co Inc Piperidine compounds and a process of preparing them
US2748140A (en) * 1954-10-07 1956-05-29 Rohm & Haas 3-hydroxymethyl-4-phenyltetrahydro-pyridines and their esters
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3479346A (en) * 1961-08-08 1969-11-18 Sterling Drug Inc N-acyl-n- (and n,n-bis-) ((1-piperidyl)-lower-alkyl)amines
US3158616A (en) * 1962-03-16 1964-11-24 Boehringer Sohn Ingelheim Nu-substituted 4-aryl-4-alkanoyloxypiperidines
US3845064A (en) * 1972-10-24 1974-10-29 Wyeth John & Brother Ltd Piperidinethioamides

Also Published As

Publication number Publication date
FI753525A (fr) 1976-06-18
US4048314A (en) 1977-09-13
BE837878A (fr) 1976-05-14
CA1053230A (fr) 1979-04-24
US4146629A (en) 1979-03-27
AU1038176A (en) 1977-07-28

Similar Documents

Publication Publication Date Title
SE7513199L (sv) Emulsioner och forfarande for framstellning derav
SE7802933L (sv) Nya cefem- och cefamforeningar och forfaranden for deras framstellning
SE427662B (sv) Alkoxisilanklusterforeningar och forfarande for deras framstellning
SE400571B (sv) Nya reaktiva dioxozinfergemnen och sett for deras framstellning
SE431746B (sv) Forfarande for framstellning av d-fenylglycinamid eller d-fenylglycin och l-fenylglycin
SE7514177L (sv) Nya 4-arylpiperidinderivat och forfaranden for deras framstellning
SE7610563L (sv) Alkoxisilanolklusterforeningar och forfarande for deras framstellning
SE7503812L (sv) Nya prostaglandinanaloger och forfarande for deras framstellning.
SE418617B (sv) Beta-aminoetylsilan och forfarande for framstellning derav
SE7511932L (sv) Aralifatiska kveveforeningar och forfarande for framstellning derav
SE7514447L (sv) Nya prostaglandin-analoger och forfaranden for deras framstellning
SE7508642L (sv) 7-metoxi-6-tia-tetracykliner och forfarande for framstellning derav
SE7506839L (sv) Nya 5-aryl-2-furamidiner och forfarande for deras framstellning
SE7512354L (sv) Pyrrolidoner och forfarande for deras framstellning
SE7514113L (sv) 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler och forfarande for deras framstellning
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
SE7511931L (sv) Penicilliner och forfarande for framstellning derav
SE7509441L (sv) Athelminitiskt aktiva 2-karbalkoxiamino-bensimidazolyl-5(6)-sulfonsyra-fenylestrar och forfarande for deras framstellning
SE7514344L (sv) 3-fluorobensodiazepiner och forfarande for framstellniing derav
SE7706059L (sv) Nya 1-aryloxi-2-hydroxi-3-aminopropaner och forfarande for deras framstellning
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
SE7504181L (sv) Tetracyklinderivat och forfarande for deras framstellning
SE7605069L (sv) 14beta-hydroxy 3-deoxikardenolider och forfarande for deras framstellning
SE7513136L (sv) Heterocykliska foreningar och forfarande for framstellning derav
SE7613948L (sv) Nya pyrrolidoner och forfarande for deras framstellning